Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases-Reference-Cited by-同舟云学术

Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases

Published:2019-04-02 Issue:2 Volume:71 Page:285-293
ISSN:2038-131X
Container-title:Updates in Surgery
language:en
Short-container-title:Updates Surg

Author:

Di Sandro Stefano, ,Centonze Leonardo,Pinotti Enrico,Lauterio Andrea,De Carlis Riccardo,Romano Fabrizio,Gianotti Luca,De Carlis Luciano

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s13304-019-00649-w.pdf

Reference30 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

2. Lafaro KJ, Demirjian AN, Pawlik TM (2015) Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am 24:1–17

3. Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314

4. Ruzzenente A, Guglielmi A, Sandri M et al (2012) Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 16:301–311 (discussion 311)

5. Qi X, Tang Y, An D et al (2014) Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. J Clin Gastroenterol 48(5):450–457

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic review;Langenbeck's Archives of Surgery;2024-09-13

2. Tumor burden score as a prognostic factor in patients with intermediate and locally advanced hepatocellular carcinoma undergoing liver resection: an attempt to extend resectability criteria;HPB;2024-09

3. TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study;BMC Cancer;2024-06-11

4. A preoperative model to predict overall survival in patients with hepatoma undergoing resection;The American Journal of Surgery;2024-05

5. NPC1 promotes autophagy with tumor promotion and acts as a prognostic model for hepatocellular carcinoma;Gene;2024-03